PL3617199T3 - Crystal form and salt of 3-(3,5-dichloro-4-hydroxybenzoyl)-1,1-dioxo-2,3-dihydro-1,3-benzothiazole - Google Patents

Crystal form and salt of 3-(3,5-dichloro-4-hydroxybenzoyl)-1,1-dioxo-2,3-dihydro-1,3-benzothiazole

Info

Publication number: PL3617199T3
Authority: PL; Poland
Prior art keywords: hydroxybenzoyl; benzothiazole; dioxo; dichloro; dihydro
Prior art date: 2017-04-28

Application number

PL18791567.3T

Other languages

Polish (pl)

Inventor

Junichiro Uda

Seiichi Kobashi

Misa HASEGAWA

Original Assignee

Fuji Yakuhin Co., Ltd.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2017-04-28

Filing date

2018-04-27

Publication date

2024-01-22

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=63918527&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3617199(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2018-04-27 Application filed by Fuji Yakuhin Co., Ltd. filed Critical Fuji Yakuhin Co., Ltd.

2024-01-22 Publication of PL3617199T3 publication Critical patent/PL3617199T3/en

Links

VOFLAIHEELWYGO-UHFFFAOYSA-N (3,5-dichloro-4-hydroxyphenyl)-(1,1-dioxo-2h-1,3-benzothiazol-3-yl)methanone Chemical compound C1=C(Cl)C(O)=C(Cl)C=C1C(=O)N1C2=CC=CC=C2S(=O)(=O)C1 VOFLAIHEELWYGO-UHFFFAOYSA-N 0.000 title 1
239000013078 crystal Substances 0.000 title 1
150000003839 salts Chemical class 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Physical Education & Sports Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Cosmetics (AREA)

PL18791567.3T 2017-04-28 2018-04-27 Crystal form and salt of 3-(3,5-dichloro-4-hydroxybenzoyl)-1,1-dioxo-2,3-dihydro-1,3-benzothiazole PL3617199T3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2017099334		2017-04-28
PCT/JP2018/017128 WO2018199277A1 (en)	2017-04-28	2018-04-27	Crystal form and salt of 3-(3,5-dichloro-4-hydroxybenzoyl)-1,1-dioxo-2,3-dihydro-1,3-benzothiazole

Publications (1)

Publication Number	Publication Date
PL3617199T3 true PL3617199T3 (en)	2024-01-22

Family

ID=63918527

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL18791567.3T PL3617199T3 (en)	2017-04-28	2018-04-27	Crystal form and salt of 3-(3,5-dichloro-4-hydroxybenzoyl)-1,1-dioxo-2,3-dihydro-1,3-benzothiazole

Country Status (19)

Country	Link
US (1)	US10752601B2 (en)
EP (1)	EP3617199B1 (en)
JP (1)	JP7132211B2 (en)
KR (1)	KR102597986B1 (en)
CN (1)	CN110914246B (en)
AU (1)	AU2018256993B9 (en)
BR (1)	BR112019018840B1 (en)
ES (1)	ES2958064T3 (en)
HR (1)	HRP20230829T1 (en)
HU (1)	HUE063661T2 (en)
IL (1)	IL269689B (en)
MX (1)	MX393833B (en)
MY (1)	MY185728A (en)
PH (1)	PH12019501982A1 (en)
PL (1)	PL3617199T3 (en)
SG (1)	SG11201909747WA (en)
TW (1)	TWI766986B (en)
WO (1)	WO2018199277A1 (en)
ZA (1)	ZA201905817B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA3159300A1 (en) *	2019-12-09	2021-06-17	Tadashi Inoue	Solid pharmaceutical preparation
WO2026124439A1 (en) *	2024-12-10	2026-06-18	成都苑东生物制药股份有限公司	Crystal form of benzothiazole derivative, and preparation method therefor and use thereof
CN121226282B (en) *	2025-05-22	2026-06-02	远大医药科技(武汉)有限公司	A compound active pharmaceutical ingredient, a pharmaceutical composition thereof, and its uses.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR051780A1 (en)	2004-11-29	2007-02-07	Japan Tobacco Inc	FUSIONED RING COMPOUNDS CONTAINING NITROGEN AND USING THEMSELVES
US20080305169A1 (en) *	2006-05-26	2008-12-11	Japan Tobacco Inc.	Pharmaceutical Compositions Comprising Nitrogen-Containing Fused Ring Coumpounds
US20080064871A1 (en)	2006-05-26	2008-03-13	Japan Tobacco Inc.	Production Method of Nitrogen-Containing Fused Ring Compounds
GB0702458D0 (en) *	2007-02-08	2007-03-21	Astrazeneca Ab	Salts 668
AU2008345225A1 (en)	2007-12-21	2009-07-09	University Of Rochester	Method for altering the lifespan of eukaryotic organisms
JP5325065B2 (en) *	2009-09-30	2013-10-23	株式会社富士薬品	New phenol derivatives

2018
- 2018-04-27 MY MYPI2019005045A patent/MY185728A/en unknown
- 2018-04-27 HR HRP20230829TT patent/HRP20230829T1/en unknown
- 2018-04-27 BR BR112019018840-1A patent/BR112019018840B1/en active IP Right Grant
- 2018-04-27 TW TW107114384A patent/TWI766986B/en active
- 2018-04-27 JP JP2019514647A patent/JP7132211B2/en active Active
- 2018-04-27 KR KR1020197031442A patent/KR102597986B1/en active Active
- 2018-04-27 SG SG11201909747W patent/SG11201909747WA/en unknown
- 2018-04-27 IL IL269689A patent/IL269689B/en unknown
- 2018-04-27 CN CN201880027057.7A patent/CN110914246B/en not_active Ceased
- 2018-04-27 AU AU2018256993A patent/AU2018256993B9/en active Active
- 2018-04-27 PL PL18791567.3T patent/PL3617199T3/en unknown
- 2018-04-27 EP EP18791567.3A patent/EP3617199B1/en active Active
- 2018-04-27 HU HUE18791567A patent/HUE063661T2/en unknown
- 2018-04-27 ES ES18791567T patent/ES2958064T3/en active Active
- 2018-04-27 MX MX2019010710A patent/MX393833B/en unknown
- 2018-04-27 WO PCT/JP2018/017128 patent/WO2018199277A1/en not_active Ceased
- 2018-04-27 US US16/482,149 patent/US10752601B2/en active Active
2019
- 2019-08-29 PH PH12019501982A patent/PH12019501982A1/en unknown
- 2019-09-03 ZA ZA2019/05817A patent/ZA201905817B/en unknown

Also Published As

Publication number	Publication date
SG11201909747WA (en)	2019-11-28
US20190389818A1 (en)	2019-12-26
US10752601B2 (en)	2020-08-25
WO2018199277A1 (en)	2018-11-01
HUE063661T2 (en)	2024-01-28
ES2958064T3 (en)	2024-01-31
TW201843145A (en)	2018-12-16
EP3617199B1 (en)	2023-07-26
BR112019018840A2 (en)	2020-04-14
RU2019130977A (en)	2021-05-28
CA3055517A1 (en)	2018-11-01
AU2018256993B9 (en)	2023-06-22
MX2019010710A (en)	2019-12-18
AU2018256993A1 (en)	2019-10-10
RU2019130977A3 (en)	2021-07-01
NZ756927A (en)	2025-02-28
EP3617199A4 (en)	2020-11-18
KR20200002847A (en)	2020-01-08
PH12019501982A1 (en)	2020-12-07
IL269689A (en)	2019-11-28
MY185728A (en)	2021-06-01
JP7132211B2 (en)	2022-09-06
MX393833B (en)	2025-03-24
AU2018256993B2 (en)	2021-12-02
EP3617199C0 (en)	2023-07-26
TWI766986B (en)	2022-06-11
EP3617199A9 (en)	2021-03-17
BR112019018840B1 (en)	2023-12-19
EP3617199A1 (en)	2020-03-04
KR102597986B1 (en)	2023-11-02
IL269689B (en)	2022-07-01
CN110914246B (en)	2023-03-10
JPWO2018199277A1 (en)	2020-03-12
CN110914246A (en)	2020-03-24
HRP20230829T1 (en)	2023-11-10
ZA201905817B (en)	2021-05-26

Similar Documents

Publication	Publication Date	Title
IL283486A (en)	2021-07-29	Microbiocidal thiazole derivatives
ZA202001340B (en)	2021-08-25	Heterocyclic compound and use thereof
IL271459A (en)	2020-01-30	Transplant patient monitoring with cell-free dna
IL262938B (en)	2021-09-30	Microbiocidal thiazole derivatives
IL254044A0 (en)	2017-10-31	3-substituted 1,3,4-oxadiazole and thiadiazole compounds as immunomodulators
ME03422B (en)	2020-01-20	DIHYDROBENZOFURANIC COMPOUNDS FOR THE TREATMENT OF DIABETES AND OBESITY
IL255919A (en)	2018-01-31	Aryl dihydro-2h-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of ror gamma and the treatment of disease
RS67082B1 (en)	2025-09-30	Combinations of aprocitentan with further active ingredients for the treatment of resistant hypertension
IL272121A (en)	2020-03-31	Composition and methods for the treatment of myopia
ZA201905817B (en)	2021-05-26	Crystal form and salt of 3-(3,5-dichloro-4-hydroxybenzoyl)-1,1-dioxo-2,3-dihydro-1,3-benzothiazole
PT4077303T (en)	2024-08-27	Substituted thiophene carboxamides and derivatives thereof as microbicides
IL273896A (en)	2020-05-31	Crystalline forms of 3-substituted 1,2,4-oxadiazole
ZA201801089B (en)	2018-12-19	N-[2-(2-amino-6,6-disubstituted-4, 4a, 5, 6-tetrahydropyrano [3,4-d][1,3] thiazin-8a (8h)-yl) -1, 3-thiazol-4-yl] amides
IL273237A (en)	2020-04-30	Novel heterocyclic compounds as modulators of mglur7
IL279939A (en)	2021-03-01	Thiadiazine derivatives
GB201707207D0 (en)	2017-06-21	Treatment of type 1 diabetes
EP3733177A4 (en)	2021-10-27	COMPOSITION FOR THE PROTECTION OF THE CORNEA
HUE068491T2 (en)	2024-12-28	Substituted thiophene carboxamides and derivatives thereof as microbicides
PL3694843T3 (en)	2022-06-20	New salt and solid state forms of escitalopram
PT3328201T (en)	2022-02-21	Application of 7-carboxybenzo[1,2,3]thiadiazole amides as plant stimulants
ZA202000399B (en)	2021-07-28	Heterocyclylmethylidene derivatives and their use as modulators of mglur5 receptors
EP3592361C0 (en)	2023-09-13	AMINOPHOSPHINE DERIVATIVES FOR THE PREVENTION AND TREATMENT OF EYE INFLAMMATIONS
EP3717024A4 (en)	2021-08-25	GENE THERAPY FOR THE IMPROVEMENT OF EYE FUNCTIONS
PT3881845T (en)	2025-02-13	Combination of trazodone and gabapentin for the treatment of pain
SG11201708692WA (en)	2017-11-29	Salt form, crystal form and intermediate of 1,2,5-thiadiazolidine-1,1-dioxide and preparation method thereof